The third path, acquiring companies that are already winning with the GLP-1 consumer, compresses the timeline and is increasingly attractive as a result, with a protein snack brand or functional beverage company commanding considerably more value in this environment than its revenue multiple would have suggested two years ago
Coverage Review & Utilization Controls: Utilization management, such as step therapy or prior authorization for GLP-1s, is now commonplace to ensure use is appropriate and cost-effective
In another study, Boland et al
Take the next step towards achieving your wellness goals with personalized care at IUVENTUS
discovered that cyclosporine, enclosed in in-situ nanosuspension (INS) and a MS, demonstrated significantly higher concentrations in rabbit corneal tissue (1683 430 ng CsA /g cornea and 826 163 ng CsA /g cornea ) than Restasis (350 ng CsA /g cornea ) and cationic emulsions (750 ng CsA /g cornea ) [246]
Lauren is AMAZING